Diabetic dyslipidaemias

Acta Diabetologica

Volumn 36, Issue SUPPL. 3, 1999, Pages

  Betteridge, Dj ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Diabetic dyslipidaemia; Hypertriglyceridaemia; Insulin resistance; Low density lipoprotein

Indexed keywords

BLOOD CLOTTING FACTOR; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY RISK; DENSITY; DIABETES MELLITUS; DYSLIPIDEMIA; GLYCATION; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

EID: 0033376803     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Kleinman JC, Donahue RP, Harris MI (1988) Mortality among diabetics in a national health sample. Am J Epidemiol 28:389
2. Kereiakes DJ (1985) Myocardial infarction in the diabetic patient. Clin Cardiol 8:446-450
3. Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjarlmarson Å (1988) Mortality and morbidity during a five year follow-up of diabetics with myocardial infarctions. Acta Med Scand 224:31-38
4. Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C, Foster ED (1994) Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥ 65 years (report from the Coronary Artery Surgery Study (CASS) Registry). Am J Cardiol 74:334-339
5. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335:217-225
6. Brand FN, Kannel WB, Evans J, Larson MG, Wolf PA (1998) Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study. Am Heart J 136:919-927
7. Stamler J, Vaccaro O, Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Risk Group (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434-444
8. Assmann G, Schulte H (1994) Identification of individuals at high risk for myocardial infarction. Atherosclerosis 110[Suppl]:S11-S21
9. Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104
10. Austin MA, Krauss RM (1986) Genetic control of low density lipoprotein subclasses. Lancet 2:592-595
11. Betteridge DJ (1997) LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM. Diabetologia 40:S149-S151
12. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921
13. Austin MA, King MC, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506
14. Betteridge DJ (1994) Diabetic dyslipidaemia. Am J Med 96[Suppl 6A]:25S-31S
15. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff S (1995) Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44:1054-1058
16. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40:647-653
17. Radomski MW, Palmer RM, Moncada S (1987) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92:181-187
18. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000
19. Ignarro LJ (1989) Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters. Pharma Res 6:651-659
20. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, Yue DK, Betteridge DJ, Deanfield J (1996) Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 28:573-579
21. Betteridge DJ (1996) Lipids and atherogenesis in diabetes mellitus. Atherosclerosis 124[Suppl]:S43-S47
22. Mahley RW, Rall SC Jr (1995) Type III hyperlipoproteinaemia (dysbetalipoproteinaemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Sriver CR, Beaudet AL, Sly WD, Valle D (eds) The Metabolic and Mole-cular Bases of Inherited Disease, 7th edn. McGraw Hill, New York, pp 1953-1980
23. MacNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ (1987) Effect of gender, age and lipid status on low density lipoprotein subtraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 7:483-490
24. Tan KC, Cooper MB, Ling KL, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ (1995) Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin dependent diabetic subjects with and without hypertriglyceridemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113:273-287
25. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS (1991) Fasting hypertriglyceridaemia in non-insulin dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72:934-944
26. Hamsten A, Wiman B, de Faire U, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563
27. Taskinen M-R, Lahdenperä S, Syvänne M (1996) New insights into lipid metabolism in non-insulin-dependent diabetes mellitus. Ann Med 28:335-340